DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Weber-Schoendorfer C, Oppermann M, Wacker E et al. on behalf of the network of French pharmacovigilance centers.
Increased risk of birth defects after TNF-α inhibitor therapy during pregnancy? A prospective multicenter cohort study (Abstract).
Birth Defects Research A 2014;
100: 523
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.